AEON.WS

AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share
AEON.WS

Delisted

AEON.WS was delisted on the 26th of April, 2024.

39 hedge funds and large institutions have $6.66M invested in AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share in 2021 Q2 according to their latest regulatory filings, with 39 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
39
Holders Change
+39
Holders Change %
% of All Funds
0.68%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
39
Increased
Reduced
Closed
Calls
$1.09M
Puts
Net Calls
+$1.09M
Net Calls Change
+$1.09M
Name Holding Trade Value Shares
Change
Shares
Change %
SC
26
Sculptor Capital
New York
$51K +$51K +50,000 New
FCM
27
Farallon Capital Management
California
$50K +$50K +49,995 New
DCM
28
Dupont Capital Management
Delaware
$50K +$50K +49,999 New
AA
29
AQR Arbitrage
Connecticut
$50K +$50K +50,000 New
AR
30
Advisory Research
Illinois
$49K +$49K +48,719 New
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$34K +$34K +33,333 New
MCM
32
Moore Capital Management
New York
$34K +$34K +33,333 New
CAC
33
Cowen and Company
New York
$25K +$25K +25,000 New
EC
34
EJF Capital
Virginia
$10K +$10K +10,000 New
CC
35
Centiva Capital
New York
$10K +$10K +10,066 New
AA
36
Ancora Advisors
Ohio
$6K +$6K +5,589 New
UBS Group
37
UBS Group
Switzerland
$3K +$3K +2,700 New
Qube Research & Technologies (QRT)
38
Qube Research & Technologies (QRT)
United Kingdom
$3K +$3K +2,979 New